13Oct

Improved Nucleic Acid Isolation

The QuickGene series of instruments and kits from Alpha Laboratories provides a novel, innovate method for DNA and RNA extraction from a vast number of sample types, all without the need for strong centrifugation steps, or centrifugation at all.  Improve workflow and remove the danger of unbalanced centrifuges and the hassle of overbooked machines.

 

The range of QuickGene kits enables extraction of DNA and RNA from samples up to 2mL in size and from a plethora of different sources, including viruses, bacteria, cultured cells, whole blood, animal and plant tissue.

 

As with other solid-phase extraction techniques QuickGene passes samples through a thin hydrophobic membrane allowing hydrophilic molecules to pass through whilst keeping hydrophobic molecules, such as nucleic acids, retained in the membrane for elution and collection.  QuickGene porous membranes are just 100μm thick, merely 10% of the size of traditional 1000μm thick glass fibre membranes.

 

Using compressed air is a more gentle process, protecting nucleic acids which in turn provides longer, more complete strands, all whilst retaining impeccable sample purity and yield, giving more confidence in results.

 

The range encompasses two instruments for semi-automation, two instruments for full automation and an adapter to allow seamless change between the extensive number of kits.

 

The simplicity and ease of use of the QuickGene instruments allows for quick and simple staff training, resulting in top quality extraction every time in a rapid, simple process. It is perfect for PCR testing or other downstream applications in any size lab.

 

Please visit www.alphalabs.co.uk/quickgene  for further information or contact Alpha Laboratories on 0800 38 77 32 or email marketing@alphalabs.co.uk  

Related

MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer

Partnership aimed at the development of molecular diagnostic assays on Biocartis’ fully automated I...

Read More >

BBI Solutions demonstrates internal antibody development capabilities while expanding their infectious disease reagent suite

BBI Solutions has released four new antibodies specific for the HIV-1 p24 capsid protein. The antibo...

Read More >

OGT continues move into molecular diagnostics markets with MDSAP certification

Certification of new Cambridge facility smooths path to future IVD approvals

Read More >

Mologic receives a $4.8m grant to establish the centre for advanced rapid diagnostics ("card")

Mologic is pleased to announce that we are in receipt of a grant from the Bill & Melinda Gates Found...

Read More >

In Brief This Week: VolitionRx, Bio-Techne, Biocept, Meridian Bioscience, and More

NEW YORK (360Dx) – VolitionRx reported a second quarter net loss of $3.5 million, or $.13 per share...

Read More >

Psyros Diagnostics Ltd. Awarded £400K Innovate UK Smart Award to accelerate development of their ground-breaking ultra-sensitive IVD technology

30 Sept. 2019, UKCoronary heart disease is one of the leading causes of death within the UK. Every d...

Read More >